13148_2019_742_MOESM3_ESM.pdf (325.15 kB)
MOESM3 of Epigenetic silencing of MEIS2 in prostate cancer recurrence
journal contribution
posted on 2019-10-23, 08:27 authored by Maibritt Nørgaard, Christa Haldrup, Marianne Bjerre, Søren Høyer, Benedicte Ulhøi, Michael Borre, Karina SørensenAdditional file 3: Figure S1. MDS plots of PC and AN samples from the discovery cohort. For the 450K data, the 1000 most variable CpG sites were used, whereas the 150 most variable genes were used for the RNAseq data.